Myasthenia gravis, other antibodies positive (Q88647): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A Miastenia Gravis (MG) generalizada de início tardio, seja em homens ou mulheres, está associada a timos atróficos. A maioria dos pacientes de início tardio (>50 anos), tanto do sexo masculino quanto do feminino, são AChR positivos e, além disso, costumam ter anticorpos antiestriatais incluindo anticorpos antitina, anti-receptor de rianodina (RyR) e anti-Kv1.4. Esses anticorpos estão associados a uma forma grave de MG e são mais frequentemente encontrados em MG associada a timoma. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Late-onset generalised Myasthenia Gravis (MG), either male or female, is associated with atrophic thymuses. Most late-onset (>50 years) patients, either male or female, are AChR positive and in addition often have anti-striational antibodies including anti-titin, ryanodine receptor (RyR), and Kv1.4 antibodies. These antibodies are associated with a severe form of MG and are more frequently found in thymoma-associated MG. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/2004419909 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_2004419909 | |||||||||||||||
| Property / CURIE: CID11:ID_2004419909 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_2004419909 | |||||||||||||||
| Property / Canary Token: dki-india-ID_2004419909 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:58, 15 August 2026
Late-onset generalised Myasthenia Gravis (MG), either male or female, is associated with atrophic thymuses. Most late-onset (>50 years) patients, either male or female, are AChR positive and in addition often have anti-striational antibodies including anti-titin, ryanodine receptor (RyR), and Kv1.4 antibodies. These antibodies are associated with a severe form of MG and are more frequently found in thymoma-associated MG.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2004419909 |
||
| English | Myasthenia gravis, other antibodies positive |
Late-onset generalised Myasthenia Gravis (MG), either male or female, is associated with atrophic thymuses. Most late-onset (>50 years) patients, either male or female, are AChR positive and in addition often have anti-striational antibodies including anti-titin, ryanodine receptor (RyR), and Kv1.4 antibodies. These antibodies are associated with a severe form of MG and are more frequently found in thymoma-associated MG. |
Statements
CID11:ID_2004419909
0 references
dki-india-ID_2004419909
0 references
Concluído
0 references
13 August 2026
0 references
